ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 3.425
-0.105 (-2.97%)
Dec 16, 2025, 10:13 AM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €122.41 million as of December 16, 2025. Its market cap has increased by 175.78% in one year.
Market Cap
122.41M
Enterprise Value
123.15M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.43
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 122.41M, a decrease of -42.84%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 121.54M | 194.54% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | 24.29M | 229.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 130.09B |
| Sanofi | 101.38B |
| Sartorius Stedim Biotech | 19.97B |
| bioMérieux | 12.64B |
| Eurofins Scientific SE | 10.21B |
| Ipsen | 9.94B |
| ABIVAX Société Anonyme | 8.18B |
| Virbac | 2.84B |